Found 0 matching trials
Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis PHASE4 The purpose of this study is to better understand the mechanism of action (...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab PHASE2 The study will test the effectiveness (rate of complete remissions, total r...
Show More Location
Community based hemato-oncology medical office
Learn More & Join Trial
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML PHASE2 In this study, the investigators conducted a phase II trial that evaluated ...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia PHASE2 The goal of this clinical trial is to evaluate the response and safety of C...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma PHASE2 This phase II trial studies how well giving vorinostat, cladribine, and rit...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Learn More & Join Trial
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS PHASE4 The DELIVER-MS study seeks to answer the question: Does early treatment wit...
Show More Status
Active Not Recruiting
Location
University of Colorado-Anschutz Medical Campus
Learn More & Join Trial
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) PHASE2 Primary Objectives:
1. To determine the response rate, progression-free su...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML PHASE3 Aim: To evaluated if cladribine based conditioning (CBA) could decrease rel...
Show More Location
Shanghai general hospital, Shanghai Jiaotong university school of medicine
Learn More & Join Trial
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL PHASE2 RATIONALE: Drugs used in chemotherapy, such as cladribine, use different wa...
Show More Location
Kantonspital Aarau
Learn More & Join Trial